$NVAX Archangel Angel Michael will destroy all the shorters and $OCGN shareholder for competing that shirt vaccines to the best Novavax vaccine. $NVAX is going to $400-$450 very soon: Expectations for further gains in the stock has added pressure on short sellers who have more than $1.1 billion worth of outstanding bets against the company as of April 29, according to S3 Partners data. So far this year Novavax short sellers have lost more than $800 million, according to Ihor Dusaniwsky, S3’s managing director of predictive analytics.